Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance

Satrajit Roychoudhury, Nicolas Scheuer, Beat Neuenschwander

Background: Well-designed phase II trials must have acceptable error rates relative to a pre-specified success criterion, usually a statistically significant p-value. Such standard…